PADAYATTIL JOSE, SEENA
 Distribuzione geografica
Continente #
NA - Nord America 2.124
AS - Asia 189
EU - Europa 169
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.487
Nazione #
US - Stati Uniti d'America 2.122
CN - Cina 142
IT - Italia 43
SE - Svezia 38
FI - Finlandia 36
VN - Vietnam 27
GB - Regno Unito 19
IN - India 9
JP - Giappone 9
NL - Olanda 8
DE - Germania 6
EU - Europa 5
UA - Ucraina 5
BE - Belgio 4
FR - Francia 3
IE - Irlanda 3
CA - Canada 2
CZ - Repubblica Ceca 1
ES - Italia 1
KZ - Kazakistan 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
Totale 2.487
Città #
Fairfield 399
Woodbridge 235
Chandler 228
Ashburn 182
Ann Arbor 173
Houston 172
Cambridge 155
Seattle 128
Wilmington 122
Beijing 56
San Diego 33
Medford 28
Princeton 28
Dong Ket 27
Des Moines 26
Nanjing 20
Helsinki 15
Padova 14
Boardman 12
Nanchang 9
Redwood City 7
New York 6
Shenyang 6
Falls Church 5
Hebei 5
Hefei 5
London 5
Zhengzhou 5
Dearborn 4
Jinan 4
Pune 4
Brussels 3
Dublin 3
Genoa 3
Jiaxing 3
Mestre 3
Norwalk 3
Bertinoro 2
Changsha 2
Gavirate 2
Groningen 2
Guangzhou 2
Kharkiv 2
Kunming 2
Ningbo 2
Ogden 2
Stockholm 2
Tappahannock 2
Tianjin 2
Tokyo 2
Almaty 1
Amsterdam 1
Birmingham 1
Bologna 1
Borås 1
Chongqing 1
Columbus 1
Edinburgh 1
Fragneto Monforte 1
Hendon 1
Kilburn 1
Kuala Lumpur 1
Lanzhou 1
Las Vegas 1
Lisbon 1
Los Angeles 1
Madrid 1
Orange 1
Pearland 1
Phoenix 1
Quzhou 1
Redmond 1
Shanghai 1
Taiyuan 1
Taizhou 1
Trieste 1
Vigonza 1
Walnut 1
Yuncheng 1
Totale 2.191
Nome #
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 154
Diagnosis and therapy of antiphospholipid syndrome 121
Laboratory testing for antiphospholipid syndrome 117
Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: Reference values and analysis of their physiologic and technical determinants 114
Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values 112
An unusual acute coronary syndrome: undisclosed disease hidden under a confounding clinical presentation 110
The Paradox of the Lupus Anticoagulant: History and Perspectives 106
APS - Diagnostics and challenges for the future 104
Antiphospholipid syndrome and the heart: A case series and literature review 101
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant 100
Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles 97
A Bridging Protocol in High-Thrombotic Risk Mechanical Valve Bearers Undergoing Surgery or Invasive Procedures 95
Lupus anticoagulant testing: Diluted Russell Viper Venom Time (dRVVT) 95
Correct laboratory approach to APS diagnosis and monitoring 92
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 91
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study 86
Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk 83
Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial 82
Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation 80
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naïve patients with non-valvular atrial fibrillation: Propensity score matched cohort study 79
. Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy volunteers: a normative study 78
Normal left ventricular mechanics by two-dimensional speckle-tracking echocardiography. Reference values in healthy adults 76
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation 73
Laboratory Diagnostics of Antiphospholipid Syndrome 72
Reference ranges for left ventricular geometry and function by 3D echocardiography using a vendor-independent software for quantitative analysis 63
Risk factors for intracranial hemorrhage during vitamin K antagonist therapy in patients with nonvalvular atrial fibrillation: A case-control study 61
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA2DS2VASc 1 or 2): A treatment dilemma 55
Which are the optimal settings of 3D datasets used for left ventricular quantitative analysis by three-dimensional speckle-tracking echocardiography? 37
Totale 2.534
Categoria #
all - tutte 7.978
article - articoli 7.978
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019239 0 0 0 0 0 0 0 0 0 0 126 113
2019/2020606 78 25 9 35 68 41 77 73 70 74 40 16
2020/2021299 22 18 15 40 8 25 14 31 40 14 32 40
2021/2022465 27 65 53 30 15 30 32 49 13 11 35 105
2022/2023382 71 49 8 59 51 43 3 33 39 2 22 2
2023/2024122 5 22 13 14 5 25 11 19 5 3 0 0
Totale 2.534